Nima Farzan

Nima Farzan

Director/Board Member at KEROS THERAPEUTICS, INC.

Net worth: 104 507 $ as of 2026-06-29

50 year
Health Technology
Consumer Services
Commercial Services

Profile

Nima M.
Farzan
is Chief Executive Officer at Latigo Biotherapeutics, Inc. since 2024.
Mr. Farzan serves as Independent Director at Keros Therapeutics, Inc. since 2020.
Mr. Farzan is a Trustee at The Hamlin School.
Former roles include President, Chief Executive Officer & Director at Kinnate Biopharma, Inc. from 2020 to 2024; President, Chief Executive Officer & Director at Emergent Travel Health, Inc. from 2015 to 2018; President & Chief Executive Officer at Paxvax Corp.
from 2015 to 2018; Director-Strategic Marketing at DoubleTwist, Inc. from 1997 to 1999; Director-Disease Area Strategy at Novartis AG from 2003 to 2011; Associate at The Boston Consulting Group, Inc.; Vice President-Marketing at Novartis Vaccines & Diagnostics, Inc.; Member at Coalition for Epidemic Preparedness Innovations; and Venture Partner at Foresite Capital Management LLC in 2024.
Education includes undergraduate studies at Stanford University and an MBA from Harvard Business School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-03 9,767 ( 0.05% ) 104 507 $ 2026-06-29

Nima Farzan active positions

CompaniesPositionStart
KEROS THERAPEUTICS, INC. Director/Board Member 2020-02-29
Corporate Officer/Principal -
Chief Executive Officer 2024-07-21

Former positions of Nima Farzan

CompaniesPositionEnd
Corporate Officer/Principal 2024-06-30
KINNATE BIOPHARMA INC. Chief Executive Officer 2024-04-02
Chief Executive Officer 2018-09-30
Paxvax Corp.
Chief Executive Officer 2018-09-30
NOVARTIS AG Corporate Officer/Principal 2010-12-31
See the detail of Nima Farzan's experience

Training of Nima Farzan

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

76

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Commercial Services

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Technology

Consumer Services

Finance

Consumer Services

Health Technology

Coalition for Epidemic Preparedness Innovations

Health Technology

Health Technology

Paxvax Corp.